According to Antelmi's review on NMS in DYT/PARK-GCH1, neuropsychiatric features, and, particularly, depression, were reported in almost all available cohort studies [11,14,15,28]. This evidence concerns the gene GCH1 and neuroleptic malignant syndrome.